Detalles de la búsqueda
1.
Does Residual Cancer Burden Predict Local Recurrence After Neoadjuvant Chemotherapy?
Ann Surg Oncol
; 29(12): 7716-7724, 2022 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-35810226
2.
Residual Cancer Burden Class Associated with Survival Outcomes in Women with Different Phenotypic Subtypes of Breast Cancer After Neoadjuvant Chemotherapy.
Ann Surg Oncol
; 29(13): 8060-8069, 2022 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-35980548
3.
Increased expression of neurotensin in high grade serous ovarian carcinoma with evidence of serous tubal intraepithelial carcinoma.
J Pathol
; 248(3): 352-362, 2019 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-30883751
4.
Rate of radial scars by core biopsy and upgrading to malignancy or high-risk lesions before and after introduction of digital breast tomosynthesis.
Breast Cancer Res Treat
; 173(1): 23-29, 2019 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-30242581
5.
Ductal Carcinoma In Situ with Microinvasion on Core Biopsy: Evaluating Tumor Upstaging Rate, Lymph Node Metastasis Rate, and Associated Predictive Variables.
Ann Surg Oncol
; 26(12): 3874-3882, 2019 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-31342378
6.
HOXA4/HOXB3 gene expression signature as a biomarker of recurrence in patients with high-grade serous ovarian cancer following primary cytoreductive surgery and first-line adjuvant chemotherapy.
Gynecol Oncol
; 149(1): 155-162, 2018 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-29402501
7.
Comparison of residual cancer burden, American Joint Committee on Cancer staging and pathologic complete response in breast cancer after neoadjuvant chemotherapy: results from the I-SPY 1 TRIAL (CALGB 150007/150012; ACRIN 6657).
Breast Cancer Res Treat
; 165(1): 181-191, 2017 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-28577078
8.
ASO Visual Abstract: Does Residual Cancer Burden Predict Local Recurrence after Neoadjuvant Chemotherapy?
Ann Surg Oncol
; 29(12): 7725, 2022 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-36100831
9.
ASO Visual Abstract: Residual Cancer Burden Class Associated with Survival Outcomes in Women with Different Phenotypic Subtypes of Breast Cancer After Neoadjuvant Chemotherapy.
Ann Surg Oncol
; 29(13): 8071, 2022 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-36057896
10.
Serial expression analysis of breast tumors during neoadjuvant chemotherapy reveals changes in cell cycle and immune pathways associated with recurrence and response.
Breast Cancer Res
; 17: 73, 2015 May 29.
Artículo
en Inglés
| MEDLINE | ID: mdl-26021444
11.
Management of flat epithelial atypia on breast core biopsy may be individualized based on correlation with imaging studies.
Mod Pathol
; 28(5): 670-6, 2015 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-25412845
12.
Thrombosis Rates and Genetic Thrombophilia Risk Among Patients With Advanced Germ Cell Tumors Treated With Chemotherapy.
Clin Genitourin Cancer
; 22(3): 102086, 2024 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-38697880
13.
Breast cancer metastatic to the liver with hepatoid features and hepatocyte paraffin 1 positivity mimicking hepatocellular carcinoma.
Histopathology
; 73(3): 529-531, 2018 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-29742288
14.
Dysregulation of the epigenome in triple-negative breast cancers: basal-like and claudin-low breast cancers express aberrant DNA hypermethylation.
Exp Mol Pathol
; 95(3): 276-87, 2013 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-24045095
15.
Low co-expression of PD-L1 and oncogenic receptor tyrosine kinases HER2 and cMET in urothelial carcinoma is associated with discordant expression between primary and metastatic sites.
Urol Oncol
; 41(8): 357.e23-357.e29, 2023 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-37295980
16.
Prognostic value of galectin-1 and galectin-3 expression in localized urothelial bladder cancer.
Transl Androl Urol
; 12(2): 228-240, 2023 Feb 28.
Artículo
en Inglés
| MEDLINE | ID: mdl-36915891
17.
Phase I study and biomarker analysis of lapatinib and concurrent radiation for locally advanced breast cancer.
Oncologist
; 17(12): 1496-503, 2012.
Artículo
en Inglés
| MEDLINE | ID: mdl-23006498
18.
Lobular histology and response to neoadjuvant chemotherapy in invasive breast cancer.
Breast Cancer Res Treat
; 136(1): 35-43, 2012 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-22961065
19.
Chemotherapy response and recurrence-free survival in neoadjuvant breast cancer depends on biomarker profiles: results from the I-SPY 1 TRIAL (CALGB 150007/150012; ACRIN 6657).
Breast Cancer Res Treat
; 132(3): 1049-62, 2012 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-22198468
20.
PLK3 amplification and tumor immune microenvironment of metastatic tumors are linked to adjuvant treatment outcomes in uterine serous cancer.
NAR Cancer
; 4(3): zcac026, 2022 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-36177381